-

$undefined

N/A

(N/A)

Protagenic Therapeutics NASDAQ:PTIX Protagenic Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics offers its services in the United States.

Location: | Website: protagenic.com | Industry: All Other Business Support Services | Sector: Administrative and Support and Waste Management and Remediation Services

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

748.2K

Cash

1.056M

Avg Qtr Burn

-1.135M

Short % of Float

0.77%

Insider Ownership

13.43%

Institutional Own.

5.38%

Qtr Updated

09/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PT00114 Details Addiction, Post-traumatic stress disorder, Treatment Resistant Depression, Social Anxiety Disorder	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.